My Dashboard
Fin. Planning
Our Solutions
Stocks
Funds
Invest in the best stock opportunities right now and every time.
Start Systematic Stock Investing …in less than a minute.
Bacil Pharma has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 921.45 |
| Cipla | 970.55 |
| Dr. Reddy's Lab | 4274.25 |
| Aurobindo Pharma | 558.85 |
| Lupin | 618.40 |
| View more.. | |
